| Document |
Document Title |
|
WO/2021/221036A1 |
The present invention provides a method for stably supplying trimethyl amine at a constant composition, said trimethyl amine containing monomethyl amine or dimethyl amine as trace impurities. The present invention is a method for supplyi...
|
|
WO/2021/218491A1 |
Provided are a nitrogen-containing compound, an electronic element, and an electronic device, and the present application belongs to the technical field of organic materials. The structure of the nitrogen-containing compound is as shown ...
|
|
WO/2021/213109A1 |
The present application belongs to the field of organic materials, and relates to an arylamine compound, an electronic component using same and an electronic device. The arylamine compound has the structure as shown in formula 1. The ary...
|
|
WO/2021/210774A1 |
The present invention provides a novel compound and an organic light-emitting element comprising same.
|
|
WO/2021/210638A1 |
Provided is a dopant capable of forming a conductor material having high electrical conductivity. The present disclosure relates to a dopant containing a radical cation represented by formula (1) and a counter anion. In formula (1), ...
|
|
WO/2021/210682A1 |
The purpose of the present invention is to provide an industrially useful production method and production device for producing a halogen oxyacid solution by reacting an organic alkaline solution with a halogen. The present invention r...
|
|
WO/2021/210898A1 |
The present invention provides a novel compound capable of improving light-emitting efficiency, stability, and lifespan of an element, an organic electrical element using the novel compound, and an electronic device thereof.
|
|
WO/2021/206477A1 |
The present invention provides: a novel compound which can improve the luminous efficiency, stability, and service life of an element; an organic electric element using same; and an electronic device thereof.
|
|
WO/2021/204774A1 |
The presently claimed invention relates to a process for the preparation of di-, tri-, or tetra fluoroarylamine by reacting polyfluorinated aryl chlorides with ammonia in the presence of a base, a metal catalyst and a ligand. Di-, tri-, ...
|
|
WO/2021/206513A1 |
The present invention relates to a pharmaceutical composition for preventing or treating muscular weakness-related diseases, comprising alverine, 4-hydroxy alverine, a derivative thereof, or a pharmaceutically acceptable salt thereof. Wh...
|
|
WO/2021/206478A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability, and lifespan of an element; an organic electrical element using same; and an electronic device comprising same.
|
|
WO/2021/203255A1 |
A method for purification of organic amines, comprising introducing a resin polymer matrix to a liquid containing at least an organic amine bonded to at least one metallic element, wherein the resin polymer matrix is embedded with an ami...
|
|
WO/2021/201287A1 |
Provided are: an asymmetric 1,2-bis(diarylamino)benzene that is useful as a material in an organic EL element; a method for producing the asymmetric 1,2-bis(diarylamino)benzene; an application of the asymmetric 1,2-bis(diarylamino)benzen...
|
|
WO/2021/200876A1 |
Provided is a compound which is represented by formula (1). (Each of the symbols in the formula is as defined in the specification.) Also provided are an organic electroluminescent element that includes the compound and an electronic dev...
|
|
WO/2021/201449A1 |
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device comprising the organic electronic element. According to the present invention, an organic e...
|
|
WO/2021/199310A1 |
The present invention is a method for producing an aromatic compound by cross-coupling reaction between a nucleophile and an electrophile, the method including a step for using Pd(OAc)2(PCy3)2 as a catalyst and causing the nucleophile an...
|
|
WO/2021/191288A1 |
The present invention relates to a process for the preparation of hexamethylenediamine by hydrogenation of adiponitrile in the presence of a Raney nickel catalyst, wherein a Raney nickel catalyst modified by treatment with carbon monoxid...
|
|
WO/2021/195671A1 |
The present invention relates to a process for preparing trientine dihydrochloride as an active pharmaceutical ingredient (API). The present invention relates to a process for the preparation of trientine dihydrochloride with a pharmaceu...
|
|
WO/2021/193654A1 |
Provided are a compound that further improves the performance of an organic EL element, an organic electroluminescent element having improved element performance, and an electronic device including such an organic electroluminescent elem...
|
|
WO/2021/158637A9 |
Various aspects of the present invention relate to cationic latex emulsions, methods of making the same, various materials including the cationic latex emulsion such as asphalt emulsions, and methods of making the asphalt emulsions. A ca...
|
|
WO/2021/189151A1 |
An antimicrobial composition is described herein. The composition comprises an antimicrobial agent, a sequestering agent, a release agent, and an optional dispersing agent. The antimicrobial agent comprises a quaternary ammonium compound...
|
|
WO/2021/191289A1 |
The present invention relates to a process for the preparation of hexamethylenediamine by hydrogenation of adiponitrile in the presence of a Raney nickel catalyst and a basic co-catalyst containing potassium hydroxide, wherein the basic ...
|
|
WO/2021/184125A1 |
It is provided an anti-aging composition comprising at least one plant extract and a carrier, the at least one plant extract is at least one of Serenoa repens, Hypericum perforatum, Ilex paraguariensis, Ocimum tenuiflorum, Solidago virga...
|
|
WO/2021/188949A1 |
3-Diarylmethylenes are disclosed. The compounds activate PP2A, suppress oncogenic kinase signaling, and negatively regulate MYC and MYCN in cancer. The compounds also induce FOXO transcription factor translocation to the nucleus by modul...
|
|
WO/2021/187796A1 |
The present application relates to: a method for removing carbon dioxide from a carbonic acid-containing diamino alkane solution, the method comprising a step of passing the carbonic acid-containing diamino alkane solution through a sepa...
|
|
WO/2021/182439A1 |
The purpose of the present invention is to provide: a borate compound-containing composition which is useful as a promoter for polymerization of olefins or dienes and which is soluble in a hydrocarbon solvent; and a manufacturing method ...
|
|
WO/2021/179049A1 |
The present invention relates to the treatment of disorders associated with oxidative stress including neuropathic pain and small synthetically derived compounds for treating such disorders.
|
|
WO/2021/182438A1 |
The purpose of the present invention is to provide a composition containing a borate compound which is useful as a cocatalyst for the solution polymerization of olefin or diene and is soluble in a hydrocarbon solvent. According to the ...
|
|
WO/2021/183542A1 |
Methods for making a dolastatin, auristatin or related compounds comprising the steps of providing a universal dolastatin core of Formula (I) reacting the C-terminal carboxylic acid group with an amine (A) to form an amide bond and react...
|
|
WO/2021/178690A1 |
The invention provides a compound of formula (I): or a salt thereof, wherein A, B, R1, R2, R3 and X have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are usef...
|
|
WO/2021/177343A1 |
Provided is a method in which a caged compound represented by general formula (I) is irradiated with light in the presence of a photosensitizer to thereby release a compound represented by general formula (II). In cases when X is O, th...
|
|
WO/2021/177290A1 |
A method for producing a mono-cross-coupled aromatic compound (3-1), said method comprising: preparation of an aromatic compound (1) that has at least two leaving groups; preparation of a compound (2) that is capable of undergoing a cros...
|
|
WO/2021/177219A1 |
Provided is a catalyst which can be used for enabling a reductive amination reaction under a low-temperature low-hydrogen-pressure condition, comprises cobalt supported on an oxide, and is characterized by being produced by a method incl...
|
|
WO/2021/174523A1 |
The present invention pertains to a method for preparing an alkylated amine by reacting a primary or secondary amine with an alcohol in the presence of hydrogen, a metal catalyst supported by photosensitive titanium oxide, and UV irradia...
|
|
WO/2021/176381A1 |
The invention relates to method for preparation of pure enantiomers of 1-(1-naphthyl)ethyl amine by preparing lactate salt with chiral lactic acid as resolving agent. The method comprises reaction of L-lactic acid or D-lactic acid with r...
|
|
WO/2021/174967A1 |
Provided is a nitrogen-containing compound, an organic electroluminescent device and an electronic apparatus, belonging to the technical field of organic material. The nitrogen-containing compound has a structure represented by chemical ...
|
|
WO/2021/174522A1 |
The present invention pertains to a method for the alkylation of amines. In particular, the present invention relates to a method for preparing N, N, N', N", N"-pentamethyldiethylenetriamine by reacting diethylenetriamine with methanol i...
|
|
WO/2021/174351A1 |
Particular antimicrobials are identified for efficacy in a composition with DispersinB to enhance biofilm dispersal and inactivation of biofilm embedded bacteria.
|
|
WO/2021/175200A1 |
Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including correspondi...
|
|
WO/2021/168988A1 |
The present invention provides a synthesis method for a fluorine-containing chiral amine compound. The synthesis method comprises: reacting an amino donor with a fluorine-containing dihydroxy ketal compound under the catalysis of transam...
|
|
WO/2021/170008A1 |
The present application relates to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic component, and an electronic device. The nitrogen-containing compound has a structure shown in formul...
|
|
WO/2021/164661A1 |
A 2-phenylcyclopropylmethylamine derivative as shown in formula I below, having affinity activity to dopamine receptors and/or 5-hydroxytryptamine receptors and used for treating mental diseases.
|
|
WO/2021/164572A1 |
The present application relates to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic element, and an electronic device. The structure of the nitrogen-containing compound is as represente...
|
|
WO/2021/161101A1 |
Disclosed is a method for preparing compound Formula S-1, comprising resolving compound Formula rac-2 with a compound of Formula 3 wherein R1 · R4, m and n are as defined in the disclosure.
|
|
WO/2021/162384A1 |
The present invention provides a novel compound capable of improving the luminous efficiency, stability, and lifespan of a device, an organic electric device using same, and an electronic device thereof.
|
|
WO/2021/163120A1 |
The present invention provides multifunctional particulates that release one or more functional compounds in response to environmental triggers and whose external surface modification imparts secondary functionalities to a selected coati...
|
|
WO/2021/161100A1 |
Disclosed is a method for preparing compound S-1 (S-1) comprising resolving compound rac-2 (rac-2) with a compound of Formula 3 wherein R1, R4, m and n are as defined in the disclosure.
|
|
WO/2021/157701A1 |
Provided are: a thiourethane resin starting material production method comprising a step in which a thiourethane resin and an active hydrogen compound are reacted to produce a thiourethane resin starting material; and a use for the thiou...
|
|
WO/2021/157702A1 |
A polyamine compound production method comprising: a first step in which a thiourethane resin and an amine compound A are reacted to produce a polyurea compound; and a second step in which the polyurea compound and an amine compound B ar...
|
|
WO/2021/155474A1 |
Cannabinoid sulfate esters, their soluble salts and stable formulations thereof, as well as their edible, beverage and medicinal applications. The cannabinoid sulfate ester salts may be used as drugs or prodrugs for treating various cond...
|
